Client news
Palatin prices an upsized $15.8 million offering and returns to NYSE American
Congratulations to Palatin Technologies (NYSE: PTN) on pricing its upsized $15.8 million public offering and its return to trading on the NYSE American.
Arx was pleased to support Palatin as the company advanced key milestones — from regaining compliance with NYSE listing standards to strengthening its capital position and a collaboration milestone with Boehringer Ingelheim, including a €5.5 million (approximately $6.5 million) payment under their retinal-disease partnership.
The offering was led by A.G.P. / Alliance Global Partners as sole book-running manager, with Laidlaw & Company (U.K.) Ltd. acting as lead manager. Common shares were expected to resume trading on November 12, 2025 under the ticker PTN.